Immune response to COVID-19 vaccines in patients with multiple sclerosis treated with disease-modifying therapies.
Neurol Neurochir Pol
; 57(1): 11-13, 2023.
Article
in En
| MEDLINE
| ID: mdl-36426928
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
/
Multiple Sclerosis
Limits:
Humans
Language:
En
Journal:
Neurol Neurochir Pol
Year:
2023
Document type:
Article
Affiliation country:
Polonia